Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies
Human African trypanosomiasis is a neglected tropical disease caused by the extracellular protozoan parasite <i>Trypanosoma brucei</i>, and targeted for eradication by 2030. The COVID-19 pandemic contributed to the lengthening of the proposed time frame for eliminating human African tryp...
Main Authors: | Miebaka Jamabo, Maduma Mahlalela, Adrienne L. Edkins, Aileen Boshoff |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/15/12529 |
Similar Items
-
The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History
by: Harry P. De Koning
Published: (2020-01-01) -
Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership
by: Sonja Bernhard, et al.
Published: (2022-10-01) -
Trypanososma brucei rhodesiense Sleeping Sickness, Uganda
by: Lea Berrang-Ford, et al.
Published: (2012-10-01) -
In silico analysis of the HSP90 chaperone system from the African trypanosome, Trypanosoma brucei
by: Miebaka Jamabo, et al.
Published: (2022-09-01) -
Cell Cycle Inhibition To Treat Sleeping Sickness
by: Conrad L. Epting, et al.
Published: (2017-11-01)